宜宾手术开双眼皮有副作用吗(宜宾永久脱毛好不好) (今日更新中)

WASHINGTON, D.C. – Two different doses of a thyroid medication are being recalled because they're not potent enough.The Food and Drug Administration announced Thursday that Acella Pharmaceuticals is voluntarily recalling one lot of 15-milligram and one lot of 120-milligram NP Thyroid?, Thyroid Tablets.The products may have as low as 87% of the labeled amount of levothyroxine, which is used to treat hypothyroidism (an underactive thyroid), according to the FDA.The company’s risk statement says patients being treated for hypothyroidism who receive sub potent NP Thyroid may experience symptoms of hypothyroidism, including fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.“There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development,” wrote Acella. “In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia.”So far, Acella says it has received four reports of "adverse events" for these lot numbers, possibly related to the recall.The products subject to recall are packed in 100-count bottles. Their lot numbers are M327E19-1 and M328F19-3. And their expiration dates are Oct. 2020 and November 2020.The products were distributed nationwide to Acella’s direct accounts, including wholesalers, pharmacies, and health care offices.“Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the two above referenced lots being recalled and is arranging for return of all recalled products,” wrote the company.Anyone who is currently taking NP Thyroid from the lots being recalled should not discontinue use without contacting their health care provider for further guidance and/or a replacement prescription, according to Acella.Anyone with questions about the recall can email Acella at recall@acellapharma.com or contact a representative at 1-888-280-2044.Click here for more information. 2272

WELLINGTON, New Zealand — New Zealand Prime Minister Jacinda Ardern has become the latest world leader to congratulate President-elect Joe Biden on his election victory, saying she offered to share her nation’s expertise on dealing the coronavirus. New Zealand's response to the pandemic is largely seen as among the world's most succesful. The country of 5 million people has only reported about 2,000 cases of the virus and has only seen five deaths.Ardern was re-elected last month, largely on the back of her administration's successful response.Ardern said the tone of the 20-minute phone call Monday was warm and that Biden spoke very favorably about how New Zealand was handling the pandemic. Ardern said the two also discussed trade issues and climate change, and talked about Biden’s Irish heritage and his fond memories of visiting New Zealand a few years ago. She said she invited him to come visit again. 924

WASHINGTON (AP) — The Pentagon plans to free up a big chunk of its military airwaves in the U.S. for high-speed internet service, part of a broader push to get ahead of China in the deployment of 5G wireless technology. The Trump administration announced Monday that it has identified radio spectrum used for radar defense systems that can be shared with commercial telecommunications providers without compromising national security. White House officials said that the Federal Communications Commission will be able to auction the 100 megahertz of “mid-band” spectrum beginning in December 2021 for use as soon as mid-2022. 633

WASHINGTON, D.C. -- IBM says it is getting out of the facial recognition business over concern about how it can be used for mass surveillance and racial profiling.A letter to U.S. lawmakers Monday from new IBM CEO Arvind Krishna said the tech giant “has sunset its general purpose facial recognition and analysis software products.”Krishna’s letter called for police reforms and said “IBM firmly opposes and will not condone uses of any technology, including facial recognition technology offered by other vendors, for mass surveillance, racial profiling” and human rights violations.Krishna was addressing Democrats who recently introduced police reform legislation in Congress in response to the death of George Floyd and others in law enforcement interactions that have sparked a worldwide reckoning over racial injustice.IBM had previously tested its facial recognition software in New York City.In the letter, Krishna also called for a “national dialogue” on whether and how facial recognition should be employed by domestic law enforcement agencies.“Artificial Intelligence is a powerful tool that can help law enforcement keep citizens safe,” wrote Krishna. “But vendors and users of Al systems have a shared responsibility to ensure that Al is tested for bias, particularity when used in law enforcement, and that such bias testing is audited and reported.” 1373

WASHINGTON, D.C. – A group of bipartisan lawmakers unveiled two emergency relief bills Monday that they hope will help struggling Americans get through the COVID-19 pandemic.The same group of senators and representatives introduced a 8 billion bill earlier this month, but they couldn’t secure enough support. So, they broke the bill up into two with the hopes of passing something as the coronavirus continues to ravage the country.One bill is called the Bipartisan COVID-19 Emergency Relief Act of 2020. It would provide as much as 8 billion in relief to American students, families, businesses, workers, and health care providers.That measure would include additional funding for the Paycheck Protection Program, schools, unemployment insurance, vaccine distribution, coronavirus testing, and contact tracing.The other bill is called the Bipartisan State and Local Support and Small Business Protection Act of 2020. It would provide 0 billion in funding for state and local governments, as well as liability protections. Both of those issues have been sticking points in relief negotiations.During a press conference introducing the legislation, Sen. Joe Manchin (D-WV) said the bills are a compromise that will carry the American people through April 1, 2021, “to ensure our healthcare crisis doesn’t become an economic catastrophe.”Sen. Susan Collins (R-ME) said she hopes leadership on both sides of the aisle use the group's legislation as a basis for a COVID-19 relief package.Negotiations are still ongoing between Democratic and Republican leadership, but both parties have said they hope to come to an agreement to provide aid the country before they leave Washington D.C. for the holidays.Watch the group lawmakers discuss the relief bills below: 1775

来源：资阳报